BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension

Authors

Institutions

Publication Details

Journal
Respiratory Medicine
Published
2025-08-27
DOI
https://doi.org/10.1016/j.rmed.2025.108318
Citations
3
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
4.56

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension

Shilpa Johri, CLAIRE THRASHER, Leslie Spikes, Harold I. Palevsky et al.
3 citations
Respiratory Medicine
Pulmonary Hypertension Research and Treatments
4.56
article

BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension

Shilpa Johri, CLAIRE THRASHER, Leslie Spikes, Harold I. Palevsky, Charles D. Burger, C. Q. Deng, Shelley Shapiro, Trushil Shah, Abubakr Bajwa, Micah R. Fisher, Peter Smith, Sandeep Sahay, Meredith Broderick, Ricardo Restrepo‐Jaramillo, Michael Eggert, Karim El‐Kersh, Gautam Ramani, Joanna M. Joly, Sapna Desai, J.P. Mehta
article en
3 citations

Abstract

No abstract available for this paper.
Respiratory MedicineVol. 248
University of Maryland, Baltimore (US), Emory Healthcare (US), University of Arizona (US), Emory University (US), University of South Florida (US), Ochsner Medical Center (US), Jacksonville College (US), Tampa General Hospital (US), University of Alabama at Birmingham (US), Cleveland Clinic Florida (US), Methodist Hospital (US), Sentara Heart Hospital (US), University of Kansas Medical Center (US), United Therapeutics (United States) (US), Pulmonary Associates (US), Mayo Clinic in Florida (US), VA Greater Los Angeles Healthcare System (US), Pulmonary and Critical Care Associates (US), University of Pennsylvania (US), The University of Texas Southwestern Medical Center (US), University of Tampa (US)
United Therapeutics Corporation
Openalex Percentile: Top 5%
Pulmonary Hypertension Research and Treatments
4.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.